Studies had also reported the role of FXR in lung cancer; for instance, FXR is highly expressed in NSCLC cells where the knockdown of FXR inhibits cell proliferation in vitro and reduced tumour growth in vivo. The gene discussed is NR1H4; the disease is non-small cell lung carcinoma.